✦ LIBER ✦

1741 COULD PATIENT AGE INFLUENCE TUMOR RECURRENCE RATE IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH BCG IMMUNOTHERAPY?

✍ Scribed by Yuge, Kazuyuki; Kikuchi, Eiji; Matsumoto, Kazuhiro; Tanaka, Nobuyuki; Takeda, Toshikazu; Miyajima, Akira; Nakagawa, Ken; Oya, Mototsugu

Book ID: 123054349
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 138 KB
Volume: 185
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.02.2068

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor size and T stage correlate indepen

Tumor size and T stage correlate independently with recurrence and progression in high-risk non-muscle-invasive bladder cancer patients treated with adjuvant BCG

✍ Zachos, Ioannis; Tzortzis, Vasileios; Mitrakas, Lampros; Samarinas, Michael; Kar 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 196 KB

1138 DNA REPAIR CAPACITY AND TUMOR RECUR

1138 DNA REPAIR CAPACITY AND TUMOR RECURRENCE IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER

✍ Donahue, Timothy F.; Donat, S. Machele; Patel, Himali; Chou, Joanne F.; Bayuga, 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 61 KB

76 Risk factors for intravesical tumor r

76 Risk factors for intravesical tumor recurrence in muscle-invasive bladder cancer patients treated with selective bladder-sparing approaches

✍ Koga, F.; Fujii, Y.; Ishioka, J-I.; Matsuoka, Y.; Numao, N.; Saito, K.; Masuda, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 145 KB

P012 Reduced overall survival and high p

P012 Reduced overall survival and high progression rates for high risk, non-muscle invasive bladder cancer in patients treated with maintenance BCG – 5 year outcomes

✍ Smith, H.E.; Robson, L.; Thorpe, A.; Johnson, M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Prognostic Value of Bcl-2 and Bax Tumor

Prognostic Value of Bcl-2 and Bax Tumor Cell Expression in Patients with Non Muscle-Invasive Bladder Cancer Receiving Bacillus Calmette-Guerin Immunotherapy

✍ Ajili, Faouzia; Kaabi, Belhassen; Darouiche, Amine; Tounsi, Haifa; Kourda, Nadia 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 919 KB

1476 PATIENTS WITH NON PRIMARY PT1 NON-M

1476 PATIENTS WITH NON PRIMARY PT1 NON-MUSCLE INVASIVE BLADDER CANCER (NMI-BC) TREATED WITH BACILLUS CALMETTE-GUERIN (BCG) ARE AT HIGHER RISK OF PROGRESSION COMPARED TO PRIMARY T1 TUMORS

✍ Alkhateeb, Sultan; Van Rhijn, Bas; Finelli, Antonio; van der Kwast, Theodorus; E 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB